Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Fail-to-Deliver
Total FTD Shares
41
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-61.3%
Negative Trend
FTD Chart
As of Apr 4, 2025,
Intra-Cellular Therapies Inc. has
41
shares failed to deliver, representing 0.00%
of the average daily volume of
3,621,742
shares. Over the past year, the monthly average FTD is
11,845
shares, with the current level 100% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Apr 04, 2025 | 131.87 | 41 | -99.74% |
| Mar 18, 2025 | 131.45 | 15.53K | +2487.83% |
| Feb 26, 2025 | 128.46 | 600 | -85.30% |
| Jan 24, 2025 | 127.35 | 4.08K | -83.78% |
| Dec 27, 2024 | 84.85 | 25.16K | -83.07% |
| Nov 12, 2024 | 88.49 | 148.62K | +7431100.00% |
| Oct 29, 2024 | 76.75 | 2 | -97.53% |
| Sep 27, 2024 | 73.3 | 81 | -69.08% |
| Aug 27, 2024 | 73.88 | 262 | -97.92% |
| Jul 23, 2024 | 78.2 | 12.59K | +89792.86% |
| Jun 24, 2024 | 75.57 | 14 | -97.10% |
| May 29, 2024 | 66.54 | 482 | +354.72% |
| Apr 04, 2024 | 67.21 | 106 | +10500.00% |
| Mar 26, 2024 | 67.33 | 1 | -99.74% |
| Feb 29, 2024 | 69.52 | 391 | -94.59% |
| Jan 23, 2024 | 66.46 | 7.23K | +1282.98% |
| Dec 27, 2023 | 73.65 | 523 | +786.44% |
| Nov 30, 2023 | 61.37 | 59 | -78.55% |
| Oct 30, 2023 | 46.37 | 275 | +292.86% |
| Sep 27, 2023 | 54.12 | 70 | -89.36% |
| Aug 14, 2023 | 57.76 | 658 | -99.11% |
| Jul 31, 2023 | 61.84 | 74.06K | +24260.20% |
| Jun 29, 2023 | 61.96 | 304 | -3.80% |
| May 30, 2023 | 59.43 | 316 | +236.17% |
| Apr 26, 2023 | 61.04 | 94 | -76.02% |
| Mar 30, 2023 | 56.05 | 392 | +259.63% |
| Feb 21, 2023 | 46.44 | 109 | -60.51% |
| Jan 30, 2023 | 46.99 | 276 | n/a |